Smetcoren C - Search Results

1

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study.

Schrooten M, Smetcoren C, Robberecht W, Van Damme P. Schrooten M, et al. Among authors: smetcoren c. Ann Neurol. 2011 Jul;70(1):79-83. doi: 10.1002/ana.22380. Epub 2011 Mar 17. Ann Neurol. 2011. PMID: 21437935

2

Case report: Superficial siderosis after brachial plexus avulsion.

Decramer T, Theys T, Smetcoren C, van Loon J, Thijs V. Decramer T, et al. Among authors: smetcoren c. Clin Neurol Neurosurg. 2016 Apr;143:104-6. doi: 10.1016/j.clineuro.2015.11.020. Epub 2016 Feb 20. Clin Neurol Neurosurg. 2016. PMID: 26914142 No abstract available.

3

SCA 8 mimicking MSA-C.

Smetcoren C, Weckhuysen D. Smetcoren C, et al. Acta Neurol Belg. 2016 Jun;116(2):221-2. doi: 10.1007/s13760-015-0523-z. Epub 2015 Aug 11. Acta Neurol Belg. 2016. PMID: 26256233 No abstract available.

4

Post-dengue sacral radiculitis presenting as a cauda equina syndrome: a case report.

Borrelli S, Sinzobahamvya E, Smetcoren C, Van Den Broucke S, Gille M. Borrelli S, et al. Among authors: smetcoren c. Acta Neurol Belg. 2019 Mar;119(1):127-128. doi: 10.1007/s13760-017-0784-9. Epub 2017 Apr 26. Acta Neurol Belg. 2019. PMID: 28444632 No abstract available.

5

An unusual association of chronic inflammatory demyelinating polyneuropathy and anti-contactin-associated protein 2 (CASPR2) syndrome.

Maldonado-Slootjes S, Smetcoren C, Piéret F, Gille M. Maldonado-Slootjes S, et al. Among authors: smetcoren c. Rev Neurol (Paris). 2021 Apr;177(4):431-433. doi: 10.1016/j.neurol.2020.07.009. Epub 2020 Sep 25. Rev Neurol (Paris). 2021. PMID: 32988629 No abstract available.

6

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

Siddiqi ZA, Nowak RJ, Mozaffar T, O'Brien F, Yountz M, Patti F; REGAIN Study Group. Siddiqi ZA, et al. Muscle Nerve. 2021 Dec;64(6):662-669. doi: 10.1002/mus.27422. Epub 2021 Oct 14. Muscle Nerve. 2021. PMID: 34590717 Clinical Trial.

7

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, Fujita KP, O'Brien FL, Booth HDE, Howard JF Jr; REGAIN Study Group. Mantegazza R, et al. Neurology. 2021 Jan 26;96(4):e610-e618. doi: 10.1212/WNL.0000000000011207. Epub 2020 Nov 23. Neurology. 2021. PMID: 33229455 Free PMC article. Clinical Trial.

8

Consistent improvement with eculizumab across muscle groups in myasthenia gravis.

Mantegazza R, O'Brien FL, Yountz M, Howard JF Jr; REGAIN study group. Mantegazza R, et al. Ann Clin Transl Neurol. 2020 Aug;7(8):1327-1339. doi: 10.1002/acn3.51121. Epub 2020 Jul 22. Ann Clin Transl Neurol. 2020. PMID: 32700461 Free PMC article. Clinical Trial.

9

Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).

Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.

10

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF; REGAIN study group. Vissing J, et al. J Neurol. 2020 Jul;267(7):1991-2001. doi: 10.1007/s00415-020-09770-y. Epub 2020 Mar 18. J Neurol. 2020. PMID: 32189108 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results